Real data, outcomes and caregiver observations from across departments and hospitals
A 2019 N G PX REPORT
Despite growing adoption of clinical aromatherapy among medical practitioners very little objective research and reporting has emerged to both quantify and qualify results in clinical settings. The Next- Generation Patient Experience (NGPX) conference partnered with WBR Insights Research Group to identify and measure developing trends in this area through both data analysis and interviews with the medical professionals.
You can download the White Paper here.
Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...
January 28, 2026 
Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...
January 28, 2026 
Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...
January 27, 2026 
Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...
January 23, 2026 
Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...
January 23, 2026 
Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...
January 23, 2026 
Jan. 21, 2026 — Fujifilm Healthcare Americas Corp. and Voicebrook, Inc. have announced a strategic partnership to ...
January 22, 2026 
Jan. 20, 2026 — The American Society of Radiologic Technicians (ASRT) Foundation has named ASRT member Danielle McDonagh ...
January 20, 2026 
Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...
January 20, 2026 
Jan. 7, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...
January 13, 2026 